Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Revenue from Customers by Products) (Details)

v3.21.1
Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Revenue, Major Customer [Line Items]        
Revenues $ 13,340,487 $ 9,943,104 $ 27,957,476 $ 20,521,120
FC2 Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues 13,340,487 9,522,271 27,094,645 19,947,195
PREBOOST Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues   420,833 862,831 573,925
U.S. Prescription Channel Segment [Member] | FC2 Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues 10,312,742 6,952,627 19,414,481 13,003,757
Global Public Health Sector [Member] | FC2 Segment [Member]        
Revenue, Major Customer [Line Items]        
Revenues $ 3,027,745 $ 2,569,644 $ 7,680,164 $ 6,943,438